Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011-2020

Rahul Aggarwal(Brigham and Women's Hospital), John W. Ostrominski(Brigham and Women's Hospital), Muthiah Vaduganathan(Brigham and Women's Hospital)

JAMA

May 8, 2024

10.1001/jama.2024.6892

Cited by 384Open Access

Abstract

This cross-sectional study assesses the prevalence and temporal evolution of cardiovascular-kidney-metabolic syndrome stages.

Related Papers

Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association

Chiadi E. Ndumele, Janani Rangaswami, Sheryl L. Chow et al.|Circulation|2023|1.6k

Development and Validation of the American Heart Association’s PREVENT Equations

Sadiya S. Khan, Kunihiro Matsushita, Yingying Sang et al.|Circulation|2023|875

Mortality in the United States, 2021

Jiaquan xu, Shelly Murphy, Kenneth D. Kochanek et al.|Unknown|2022|396

Trends in Cardiovascular Risk Factors in US Adults by Race and Ethnicity and Socioeconomic Status, 1999-2018

Jiang He, Zhengbao Zhu, Joshua D. Bundy et al.|JAMA|2021|291

Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020

John W. Ostrominski, Suzanne V. Arnold, Javed Butler et al.|JAMA Cardiology|2023|241